Access cutting-edge urinary incontinence treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access urinary incontinence specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related urinary incontinence treatment provided free
The goal of this clinical trial is to compare treatment outcomes between an oral medication (beta agonist) versus onabotulinumtoxinA injections in women with urgency urinary incontinence (UUI). Participants will be randomly selected to receive one of the two treatments. The primary outcome measure will be at 3 months, and women will be followed for a total of 12 months. Based on patient expert input, there are 2 primary outcomes: Treatment satisfaction and urinary symptom severity. The study
Sponsor: Women and Infants Hospital of Rhode Island
Check if you qualify for this urinary incontinence clinical trial in Washington Dc, DC
If you're searching for urinary incontinence treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urinary incontinence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.